Cheetah Medical Set To Compete In Fast-Growing Hemodynamic Monitoring Market
Executive Summary
In February, Cheetah Medical Inc. raised $9 million in a late financing round to support commercialization of its noninvasive, continuous hemodynamic monitoring system. It’s a product sector that’s received lots of attention recently, driven by rising cost pressures on hospitals, demographics, and new noninvasive alternatives to conventional hemodynamic monitoring technologies that require the insertion of an arterial line or pulmonary artery catheter.